Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-17

FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for the Lisinopril and Hydrochlorothiazide combination from Lupin Pharmaceuticals, formalizing an approved modification …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisinopril and Hydrochlorothiazide (Lisinopril and Hydrochlorothiazide)

Snippet

SUPPL AP for LISINOPRIL AND HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE)